Managing Comorbidities, Determinants and Disability at Start and End of TB Treatment under Routine Program Conditions in China.
6 min walking test
China
SORT IT
cigarette smoking
diabetes mellitus
disability
excess alcohol drinking
high blood pressure
mental health disorder
tuberculosis
Journal
Tropical medicine and infectious disease
ISSN: 2414-6366
Titre abrégé: Trop Med Infect Dis
Pays: Switzerland
ID NLM: 101709042
Informations de publication
Date de publication:
26 Jun 2023
26 Jun 2023
Historique:
received:
01
06
2023
revised:
21
06
2023
accepted:
23
06
2023
medline:
28
7
2023
pubmed:
28
7
2023
entrez:
28
7
2023
Statut:
epublish
Résumé
Many patients with tuberculosis (TB) have comorbidities, risk determinants and disability that co-exist at diagnosis, during and after TB treatment. We conducted an observational cohort study in 11 health facilities in China to assess under routine program conditions (i) the burden of these problems at the start and end of TB treatment and (ii) whether referral mechanisms for further care were functional. There were 603 patients registered with drug-susceptible TB who started TB treatment: 84% were symptomatic, 14% had diabetes, 14% had high blood pressure, 19% smoked cigarettes, 10% drank excess alcohol and in 45% the 6 min walking test (6MWT) was abnormal. Five patients were identified with mental health disorders. There were 586 (97%) patients who successfully completed TB treatment six months later. Of these, 18% were still symptomatic, 12% had diabetes (the remainder with diabetes failed to complete treatment), 5% had high blood pressure, 5% smoked cigarettes, 1% drank excess alcohol and 25% had an abnormal 6MWT. Referral mechanisms for the care of comorbidities and determinants worked well except for mental health and pulmonary rehabilitation for disability. There is need for more programmatic-related studies in other countries to build the evidence base for care of TB-related conditions and disability.
Identifiants
pubmed: 37505637
pii: tropicalmed8070341
doi: 10.3390/tropicalmed8070341
pmc: PMC10383887
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Références
BMC Med. 2021 Sep 9;19(1):203
pubmed: 34496845
Int J Tuberc Lung Dis. 2020 Feb 1;24(2):170-175
pubmed: 32127100
Int J Environ Res Public Health. 2021 Mar 02;18(5):
pubmed: 33801381
Eur Respir J. 2019 Mar 14;53(3):
pubmed: 30872556
Int J Tuberc Lung Dis. 2021 Feb 1;25(2):87-90
pubmed: 33656417
Chest. 2003 Jun;123(6):1988-95
pubmed: 12796179
Int J Tuberc Lung Dis. 2007 Oct;11(10):1049-61
pubmed: 17945060
Int J Tuberc Lung Dis. 2018 Jun 1;22(6):649-654
pubmed: 29862949
BMJ Open. 2022 Nov 21;12(11):e058013
pubmed: 36410818
Int J Chron Obstruct Pulmon Dis. 2017 Dec 11;12:3533-3539
pubmed: 29270007
Sci Rep. 2017 Apr 24;7(1):1090
pubmed: 28439071
BMC Med. 2011 Jul 01;9:81
pubmed: 21722362
Int J Infect Dis. 2021 Sep;110:403-409
pubmed: 34332089
Am Fam Physician. 2018 Oct 15;98(8):508-515
pubmed: 30277728
Trop Med Infect Dis. 2021 Sep 10;6(3):
pubmed: 34564548
Lancet Infect Dis. 2020 Jan;20(1):123-132
pubmed: 31676242
Lancet. 2018 Sep 22;392(10152):987-988
pubmed: 30146328
Int J Epidemiol. 2010 Feb;39(1):149-55
pubmed: 19820104
Am J Respir Crit Care Med. 2023 Apr 15;207(8):1080-1088
pubmed: 36746196
Life (Basel). 2021 Nov 15;11(11):
pubmed: 34833112
Lancet Glob Health. 2021 Dec;9(12):e1679-e1687
pubmed: 34798027
Eur J Clin Nutr. 1988 May;42(5):445-50
pubmed: 3396531
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Int J Tuberc Lung Dis. 2019 Feb 1;23(2):195-202
pubmed: 30808452
Trop Med Int Health. 2012 Oct;17(10):1294-301
pubmed: 22830945
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
Ann Epidemiol. 2022 Apr;68:24-31
pubmed: 34973421
NPJ Prim Care Respir Med. 2019 Apr 5;29(1):10
pubmed: 30952884
Lancet. 2019 Mar 30;393(10178):1331-1384
pubmed: 30904263
Respiration. 2021;100(8):751-763
pubmed: 33401266
Int J Infect Dis. 2021 Aug;109:123-128
pubmed: 34224869
Public Health Action. 2014 Jun 21;4(2):79-84
pubmed: 26399203
Public Health Action. 2018 Jun 21;8(2):37-49
pubmed: 29946519
Int J Tuberc Lung Dis. 2020 Aug 1;24(8):820-828
pubmed: 32912387
Int J Tuberc Lung Dis. 2004 Mar;8(3):286-98
pubmed: 15139466
BMJ Glob Health. 2018 Jul 23;3(4):e000745
pubmed: 30057796
J Clin Diagn Res. 2017 Apr;11(4):OC34-OC38
pubmed: 28571188
Front Public Health. 2021 Oct 08;9:756717
pubmed: 34692632
Int J Tuberc Lung Dis. 2020 Jan 1;24(1):73-82
pubmed: 32005309
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Int J Tuberc Lung Dis. 2018 Nov 1;22(11):1277-1285
pubmed: 30355406
Glob Ment Health (Camb). 2020 Jan 22;7:e4
pubmed: 32076574
Eur Respir J. 2011 Jan;37(1):150-6
pubmed: 20525717